3zbf

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
'''Unreleased structure'''
+
{{STRUCTURE_3zbf| PDB=3zbf | SCENE= }}
 +
===Structure of Human ROS1 Kinase Domain in Complex with Crizotinib===
 +
{{ABSTRACT_PUBMED_23724914}}
-
The entry 3zbf is ON HOLD until Paper Publication
+
==Disease==
 +
[[http://www.uniprot.org/uniprot/ROS1_HUMAN ROS1_HUMAN]] Note=A chromosomal aberration involving ROS1 is found in a glioblastoma multiforme sample. An intra-chromosomal deletion del(6)(q21q21) is responsible for the formation of GOPC-ROS1 chimeric protein which is localized to the Golgi and has a constitutive receptor tyrosine kinase activity. A SLC34A2-ROS1 chimeric protein produced in non-small cell lung cancer cells also retains a constitutive kinase activity. A third type of chimeric protein CD74-ROS1 was also identified in those cells.<ref>PMID:12661006</ref>
-
Authors: McTigue, M., Deng, Y., Liu, W., Brooun, A., Stewart, A.
+
==Function==
 +
[[http://www.uniprot.org/uniprot/ROS1_HUMAN ROS1_HUMAN]] Orphan receptor tyrosine kinase (RTK) that plays a role in epithelial cell differentiation and regionalization of the proximal epididymal epithelium. May activate several downstream signaling pathways related to cell differentiation, proliferation, growth and survival including the PI3 kinase-mTOR signaling pathway. Mediates the phosphorylation of PTPN11, an activator of this pathway. May also phosphorylate and activate the transcription factor STAT3 to control anchorage-independent cell growth. Mediates the phosphorylation and the activation of VAV3, a guanine nucleotide exchange factor regulating cell morphology. May activate other downstream signaling proteins including AKT1, MAPK1, MAPK3, IRS1 and PLCG2.<ref>PMID:11094073</ref> <ref>PMID:16885344</ref>
-
Description: Structure of Human ROS1 Kinase Domain in Complex with Crizotinib
+
==About this Structure==
 +
[[3zbf]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3ZBF OCA].
 +
 
 +
==Reference==
 +
<ref group="xtra">PMID:023724914</ref><references group="xtra"/><references/>
 +
[[Category: Homo sapiens]]
 +
[[Category: Receptor protein-tyrosine kinase]]
 +
[[Category: Brooun, A.]]
 +
[[Category: Deng, Y.]]
 +
[[Category: Liu, W.]]
 +
[[Category: McTigue, M.]]
 +
[[Category: Stewart, A.]]
 +
[[Category: Transferase]]
 +
[[Category: Tyrosine kinase]]

Revision as of 14:05, 19 June 2013

Template:STRUCTURE 3zbf

Contents

Structure of Human ROS1 Kinase Domain in Complex with Crizotinib

Template:ABSTRACT PUBMED 23724914

Disease

[ROS1_HUMAN] Note=A chromosomal aberration involving ROS1 is found in a glioblastoma multiforme sample. An intra-chromosomal deletion del(6)(q21q21) is responsible for the formation of GOPC-ROS1 chimeric protein which is localized to the Golgi and has a constitutive receptor tyrosine kinase activity. A SLC34A2-ROS1 chimeric protein produced in non-small cell lung cancer cells also retains a constitutive kinase activity. A third type of chimeric protein CD74-ROS1 was also identified in those cells.[1]

Function

[ROS1_HUMAN] Orphan receptor tyrosine kinase (RTK) that plays a role in epithelial cell differentiation and regionalization of the proximal epididymal epithelium. May activate several downstream signaling pathways related to cell differentiation, proliferation, growth and survival including the PI3 kinase-mTOR signaling pathway. Mediates the phosphorylation of PTPN11, an activator of this pathway. May also phosphorylate and activate the transcription factor STAT3 to control anchorage-independent cell growth. Mediates the phosphorylation and the activation of VAV3, a guanine nucleotide exchange factor regulating cell morphology. May activate other downstream signaling proteins including AKT1, MAPK1, MAPK3, IRS1 and PLCG2.[2] [3]

About this Structure

3zbf is a 1 chain structure with sequence from Homo sapiens. Full crystallographic information is available from OCA.

Reference

  • Awad MM, Katayama R, McTigue M, Liu W, Deng YL, Brooun A, Friboulet L, Huang D, Falk MD, Timofeevski S, Wilner KD, Lockerman EL, Khan TM, Mahmood S, Gainor JF, Digumarthy SR, Stone JR, Mino-Kenudson M, Christensen JG, Iafrate AJ, Engelman JA, Shaw AT. Acquired Resistance to Crizotinib from a Mutation in CD74-ROS1. N Engl J Med. 2013 Jun 1. PMID:23724914 doi:10.1056/NEJMoa1215530
  1. Charest A, Lane K, McMahon K, Park J, Preisinger E, Conroy H, Housman D. Fusion of FIG to the receptor tyrosine kinase ROS in a glioblastoma with an interstitial del(6)(q21q21). Genes Chromosomes Cancer. 2003 May;37(1):58-71. PMID:12661006 doi:10.1002/gcc.10207
  2. Zeng L, Sachdev P, Yan L, Chan JL, Trenkle T, McClelland M, Welsh J, Wang LH. Vav3 mediates receptor protein tyrosine kinase signaling, regulates GTPase activity, modulates cell morphology, and induces cell transformation. Mol Cell Biol. 2000 Dec;20(24):9212-24. PMID:11094073
  3. Charest A, Wilker EW, McLaughlin ME, Lane K, Gowda R, Coven S, McMahon K, Kovach S, Feng Y, Yaffe MB, Jacks T, Housman D. ROS fusion tyrosine kinase activates a SH2 domain-containing phosphatase-2/phosphatidylinositol 3-kinase/mammalian target of rapamycin signaling axis to form glioblastoma in mice. Cancer Res. 2006 Aug 1;66(15):7473-81. PMID:16885344 doi:10.1158/0008-5472.CAN-06-1193

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools